Physician profile
Robert Liu
NPI 1578135760
$5,893.35
in general payments reported to CMS, 2019-2025
9 companies · $5,199 in 2025
The $5,199 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $484 · 2024: $211 · 2025: $5,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,532 · Food and Beverage: $1,786 · Travel and Lodging: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,532.00 |
| Food and Beverage | $1,786.32 |
| Travel and Lodging | $1,575.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $4,857.38 | 2024-2025 | |
| Glaxosmithkline, LLC. | $288.49 | 2023-2025 | Nucala, Benlysta |
| Pulmonx Corporation | $264.09 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Merck Sharp & Dohme LLC | $149.77 | 2024-2025 | Winrevair |
| Verona Pharma, INC. | $125.00 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $88.04 | 2024 | Ekosonic |
| Insmed, INC. | $52.81 | 2023 | |
| Jazz Pharmaceuticals INC. | $38.89 | 2025 | |
| Genentech USA, INC. | $28.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.